INS and hyperlipidemia: The CES1 protein has hydrolase activity and its inactivation leads to hyperlipidemia and increased fat deposition in peripheral tissues, obesity, fatty liver, hyperinsulinemia and insulin insensitivity and a decreased energy expenditure21.